Naloxone, the life-saving antidote: History, impact, and international programs (notice n° 1373229)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01031cam a2200169 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250629024644.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Chapuy, Mathieu |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Naloxone, the life-saving antidote: History, impact, and international programs |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2025.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 27 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Naloxone is the antidote for opioid overdoses, widely known and used across the world since the 1970s. Given its effectiveness, excellent safety profile, and the rising number of overdose-related deaths, ready-to-use forms (take-home naloxone or THN) have been developed, enabling users or their loved ones to save lives. The aim of this article is to describe the history of the development of THN and to explain why and how naloxone programs were created internationally. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Frauger, Elisabeth |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Psychotropes | 31 | 2-3 | 2025-06-24 | p. 127-143 | 1245-2092 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-psychotropes-2025-2-3-page-127?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-psychotropes-2025-2-3-page-127?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux